AUROLAB

Auro Laboratories financials

Market cap
₹167 Cr

Quarterly results

Q4 FY26: revenue up 32.8%, net profit up 148.7% against the same quarter last year.

₹ Cr · quarterly
Line itemQ1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue6 3 3 7 3 −52%9 +185%9 +208%10 +33%
EBITDA1 1 0 1 0 −98%2 +226%4 +802%3 +311%
Net profit1 0 0 0 -0 −115%1 +100%2 +3800%1 +149%
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Performance +12.1% 1Y

₹200₹250₹300Sept 25Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Sept 26

1Y: ₹229.65 on 10 Sept 2025 → ₹257.5. High ₹302.05 (18 Feb 2026), low ₹179.25 (10 Nov 2025).

Financials, as filed

Revenue fell 43.2% a year over 1 year, FY24 to FY25. Operating margin narrowed to 16.5%.

Year endingFY24FY25
Revenue₹39 Cr₹22 Cr
Operating profit₹9 Cr₹4 Cr
Operating margin22.0%16.5%
Interest₹1 Cr₹2 Cr
Depreciation₹1 Cr₹1 Cr
Net profit₹6 Cr₹1 Cr
Net margin15.9%4.8%
Cash from operations—₹5 Cr
Free cash flow—₹-19 Cr
How to read this

From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.

Balance sheet

Year endingFY25
Equity capital₹6 Cr
Reserves₹37 Cr
Borrowings₹44 Cr
Other liabilities₹23 Cr
Total liabilities₹111 Cr
Fixed assets₹77 Cr
Capital work in progress₹10 Cr
Investments₹0 Cr
Other assets₹24 Cr
Total assets₹111 Cr
How to read this

As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.

Who owns it

As disclosed at Jun 2026

Since Jun 2025, the public trimmed −0.24 pp while promoters added +0.23 pp. The shareholder count shrank 7% to 8,315.

Promoters
52.4%
DIIs
0.0%
Public
47.6%

Since Jun 2025

  • Public −0.24 pp
  • Promoters +0.23 pp
  • DIIs 0.00 pp

How it drifted, 12 quarters

Sep '23Dec '24Jun '26

Ownership split by quarter, oldest first. Sep '23: Promoters 52.1%, DIIs 0.0%, Public 47.9%.Dec '23: Promoters 52.1%, DIIs 0.0%, Public 47.9%.Mar '24: Promoters 52.1%, DIIs 0.0%, Public 47.9%.Jun '24: Promoters 52.1%, DIIs 0.0%, Public 47.8%.Sep '24: Promoters 52.1%, DIIs 0.0%, Public 47.8%.Dec '24: Promoters 52.1%, DIIs 0.0%, Public 47.8%.Mar '25: Promoters 52.2%, DIIs 0.0%, Public 47.8%.Jun '25: Promoters 52.2%, DIIs 0.0%, Public 47.8%.Sep '25: Promoters 52.2%, DIIs 0.0%, Public 47.8%.Dec '25: Promoters 52.2%, DIIs 0.0%, Public 47.8%.Mar '26: Promoters 52.2%, DIIs 0.0%, Public 47.8%.Jun '26: Promoters 52.4%, DIIs 0.0%, Public 47.6%.

Who was buying across the market this quarter →

Who bought this quarter

since Mar 2026

Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.

The same filing shows 1 holder trimming and 0 off the list — both are in the register beside this.

Who is on the register

Named in the Jun 2026 filing

Every holder of Auro Laboratories Ltd. above SEBI's 1% disclosure line, and what changed since Mar 2026.

HolderStakeChange
Auro Impex Private Ltd 18.98%+0.23 pp
Sharat Deorah 18.71%unchanged
Siddhartha Deorah 7.09%unchanged
Samridhi Deorah 3.87%unchanged
Sharat Deorah Huf 3.67%unchanged
Kirtilaben Jayantilal Mehta 3.13%unchanged
Samir Jitendra Javeri 1.63%−0.48 pp
Shikha Lohia 1.54%unchanged
Ravi Parimal Shah 1.45%unchanged
Siddhartha Deorah Huf 0.09%unchanged

A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.

Learn to analyse Auro Laboratories Ltd.

Guides on how to read this kind of business and the numbers that matter.